Effect of ganoderic acid A on a mouse model of concanavalin A-induced acute immune liver injury and its mechanism

Yi CUI; Fengjie QIAO; Jiahao QIU; Yufei LIU; Zhujun GAO; Zhi SHANG; Yueqiu GAO

doi:10.12449/JCH241211

Volume 40 Issue 12

Dec. 2024

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(12): 2415-2423

PDF( 6136 KB)

Effect of ganoderic acid A on a mouse model of concanavalin A-induced acute immune liver injury and its mechanism

DOI: 10.12449/JCH241211

Yi CUI^{1, 2},
Fengjie QIAO^{1, 2},
Jiahao QIU^{1, 2},
Yufei LIU^{1, 2},
Zhujun GAO^{1, 2},
Zhi SHANG^{1, 2},
Yueqiu GAO^{1, 2
,
,
,}

1.
Laboratory of Cell Immunity，Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine，Shanghai 201203，China
2.
Shuguang School of Clinical Medicine，Shanghai University of Traditional Chinese Medicine，Shanghai 201203，China

Research funding:

National Natural Science Foundation of China (82104606);

National Natural Science Foundation of China (81874436)

More Information

Corresponding author: GAO Yueqiu， gaoyueqiu@hotmail.com （ORCID： 0000-0001-7276-9810）
Received Date: 2024-04-28
Accepted Date: 2024-06-18
Published Date: 2024-12-25

Abstract

Abstract

Objective To investigate the therapeutic effect of ganoderic acid A （GA-A） on a mouse model of concanavalin A （ConA）-induced autoimmune hepatitis （AIH）. Methods A total of 35 mice were randomly divided into control group （NC group）， model group （ConA group）， and low-， middle-， and high-dose GA-A treatment groups （GA-A-L， GA-A-M， and GA-A-H groups， respectively）， with 7 mice in each group. ConA was injected via the caudal vein of mice to establish a classic mouse model of AIH， and different doses of GA-A were administered via intraperitoneal injection 1 hour later for treatment. Proteomic techniques were used to investigate the protective mechanism of GA-A on hepatocytes， and HL-60 cells were differentiated into dHL-60 neutrophils by all-trans retinoic acid in vitro to validate the mechanism of action of GA-A. Related indicators were measured， including inflammatory markers （the activities of serum alanine aminotransferase ［ALT］ and aspartate aminotransferase ［AST］， HE staining， and inflammation-related genes）， apoptosis markers （TUNEL staining）， neutrophils， and neutrophil extracellular trap （NET） markers （myeloperoxidase ［MPO］， citrullinated histone H3 ［CitH3］， Ly6G， and free double-stranded DNA ［dsDNA］）， and p38 phosphorylation markers. The independent samples t-test was used for comparison of continuous data between two groups； a one-way analysis of variance was used for comparison between multiple groups， and the least significant difference t-test was used for further comparison between two groups. Results Compared with the NC group， the ConA group had significant increases in the serum levels of ALT and AST （both P<0.001）， and compared with the ConA group， GA-A treatment significantly reduced the levels of ALT and AST （both P<0.01）. HE staining showed that the mice in the ConA group had significant liver necrosis， while GA-A treatment significantly reduced the area of liver necrosis and the number of TUNEL-positive cells （both P<0.05）. Compared with the ConA group， the GA-A group had significant reductions in the expression levels of the inflammatory factors interleukin-6， tumor necrosis factor-α， and interferon gamma in serum and liver tissue （all P<0.05）. The proteomic analysis showed that GA-A alleviated ConA-induced acute immune liver injury by inhibiting the release of NET and the p38 MAPK pathway. Immunofluorescent staining of mouse liver tissue showed that compared with the ConA group， the GA-A group had significant reductions in the number of MPO-positive neutrophils and the number of cells with positive Ly6G and CitH3 （all P<0.01）. Western Blot and dsDNA testing showed that GA-A significantly inhibited the levels of the NET markers dsDNA and CitH3 and the level of p38 phosphorylation in liver tissue and dHL-60 cells （all P<0.05）. Conclusion GA-A alleviates liver inflammatory response and hepatocyte death by inhibiting the p38 MAPK pathway and the release of NET， thereby alleviating ConA-induced acute immune liver injury. This study provides a theoretical basis for the use of GA-A to treat immune liver injury by regulating neutrophil function.
- Ganoderic Acid A,
- Concanavalin A,
- Hepatitis， Autoimmune,
- Extracellular Traps,
- Proteomics,
- Mice， Inbred C57BL

FullText(HTML)

References(34)

References

[1]	CHUNG YY, RAHIM MN, HENEGHAN MA. Autoimmune hepatitis and pregnancy: Considerations for the clinician[J]. Expert Rev Clin Immunol, 2022, 18( 4): 325- 333. DOI: 10.1080/1744666X.2022.2044307.
[2]	SMOLKA V, TKACHYK O, EHRMANN J, et al. Acute onset of autoimmune hepatitis in children and adolescents[J]. Hepatobiliary Pancreat Dis Int, 2020, 19( 1): 17- 21. DOI: 10.1016/j.hbpd.2019.08.004.
[3]	SHARMA R, VERNA EC, SÖDERLING J, et al. Increased mortality risk in autoimmune hepatitis: A nationwide population-based cohort study with histopathology[J]. Clin Gastroenterol Hepatol, 2021, 19( 12): 2636- 2647. DOI: 10.1016/j.cgh.2020.10.006.
[4]	TRIVEDI PJ, HIRSCHFIELD GM. Recent advances in clinical practice: Epidemiology of autoimmune liver diseases[J]. Gut, 2021, 70( 10): 1989- 2003. DOI: 10.1136/gutjnl-2020-322362.
[5]	SIRBE C, SIMU GL, SZABO I, et al. Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms[J]. Int J Mol Sci, 2021, 22( 24): 13578. DOI: 10.3390/ijms222413578.
[6]	WEI YR, LI YM, YAN L, et al. Alterations of gut microbiome in autoimmune hepatitis[J]. Gut, 2020, 69( 3): 569- 577. DOI: 10.1136/gutjnl-2018-317836.
[7]	DYSON JK, DE MARTIN E, DALEKOS GN, et al. Review article: Unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop[J]. Aliment Pharmacol Ther, 2019, 49( 5): 528- 536. DOI: 10.1111/apt.15111.
[8]	BRINKMANN V, REICHARD U, GOOSMANN C, et al. Neutrophil extracellular traps kill bacteria[J]. Science, 2004, 303( 5663): 1532- 1535. DOI: 10.1126/science.1092385.
[9]	CASTANHEIRA FVS, KUBES P. Neutrophils and NET in modulating acute and chronic inflammation[J]. Blood, 2019, 133( 20): 2178- 2185. DOI: 10.1182/blood-2018-11-844530.
[10]	MASUDA S, NAKAZAWA D, SHIDA H, et al. NETosis markers: Quest for specific, objective, and quantitative markers[J]. Clin Chim Acta, 2016, 459: 89- 93. DOI: 10.1016/j.cca.2016.05.029.
[11]	TANAKA K, KOIKE Y, SHIMURA T, et al. In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model[J]. PLoS One, 2014, 9( 11): e111888. DOI: 10.1371/journal.pone.0111888.
[12]	YIPP BG, KUBES P. NETosis: How vital is it?[J]. Blood, 2013, 122( 16): 2784- 2794. DOI: 10.1182/blood-2013-04-457671.
[13]	LOOD C, BLANCO LP, PURMALEK MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease[J]. Nat Med, 2016, 22( 2): 146- 153. DOI: 10.1038/nm.4027.
[14]	HAN F, DING ZF, SHI XL, et al. Irisin inhibits neutrophil extracellular traps formation and protects against acute pancreatitis in mice[J]. Redox Biol, 2023, 64: 102787. DOI: 10.1016/j.redox.2023.102787.
[15]	KESHARI RS, VERMA A, BARTHWAL MK, et al. Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NET release from human neutrophils[J]. J Cell Biochem, 2013, 114( 3): 532- 540. DOI: 10.1002/jcb.24391.
[16]	ZHAO XH, YANG L, CHANG N, et al. Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling[J]. Cell Death Dis, 2020, 11( 5): 379. DOI: 10.1038/s41419-020-2582-1.
[17]	RADWAN FFY, HOSSAIN A, GOD JM, et al. Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid[J]. J Cell Biochem, 2015, 116( 1): 102- 114. DOI: 10.1002/jcb.24946.
[18]	CHI BJ, WANG SQ, BI S, et al. Effects of ganoderic acid A on lipopolysaccharide-induced proinflammatory cytokine release from primary mouse microglia cultures[J]. Exp Ther Med, 2018, 15( 1): 847- 853. DOI: 10.3892/etm.2017.5472.
[19]	CHENG Y, XIE P. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway[J]. J Biochem Mol Toxicol, 2019, 33( 11): e22392. DOI: 10.1002/jbt.22392.
[20]	XU LX, YAN LJ, HUANG SP. Ganoderic acid A against cyclophosphamide-induced hepatic toxicity in mice[J]. J Biochem Mol Toxicol, 2019, 33( 4): e22271. DOI: 10.1002/jbt.22271.
[21]	MA JQ, ZHANG YJ, TIAN ZK. Anti-oxidant, anti-inflammatory and anti-fibrosis effects of ganoderic acid A on carbon tetrachloride induced nephrotoxicity by regulating the Trx/TrxR and JAK/ROCK pathway[J]. Chem Biol Interact, 2021, 344: 109529. DOI: 10.1016/j.cbi.2021.109529.
[22]	TADOKORO T, MORISHITA A, SAKAMOTO T, et al. Galectin-9 ameliorates fulminant liver injury[J]. Mol Med Rep, 2017, 16( 1): 36- 42. DOI: 10.3892/mmr.2017.6606.
[23]	RANI R, TANDON A, WANG J, et al. Stellate cells orchestrate concanavalin A-induced acute liver damage[J]. Am J Pathol, 2017, 187( 9): 2008- 2019. DOI: 10.1016/j.ajpath.2017.05.015.
[24]	WANG KC, WU WR, JIANG XW, et al. Multi-omics analysis reveals the protection of gasdermin D in concanavalin A-induced autoimmune hepatitis[J]. Microbiol Spectr, 2022, 10( 5): e0171722. DOI: 10.1128/spectrum.01717-22.
[25]	XU HL, LIU LL, CHEN YX, et al. The chemical character of polysaccharides from processed Morindae officinalis and their effects on anti-liver damage[J]. Int J Biol Macromol, 2019, 141: 410- 421. DOI: 10.1016/j.ijbiomac.2019.08.213.
[26]	HE GW, GÜNTHER C, KREMER AE, et al. PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury[J]. Gut, 2017, 66( 4): 716- 723. DOI: 10.1136/gutjnl-2015-311247.
[27]	LI XH, ZHANG YT, WANG JP, et al. zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis[J]. J Autoimmun, 2022, 133: 102904. DOI: 10.1016/j.jaut.2022.102904.
[28]	LIU FL, SHI KJ, DONG JJ, et al. Ganoderic acid A attenuates high-fat-diet-induced liver injury in rats by regulating the lipid oxidation and liver inflammation[J]. Arch Pharm Res, 2020, 43( 7): 744- 754. DOI: 10.1007/s12272-020-01256-9.
[29]	SAFFARZADEH M, JUENEMANN C, QUEISSER MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones[J]. PLoS One, 2012, 7( 2): e32366. DOI: 10.1371/journal.pone.0032366.
[30]	REN AH, DONG YB, MIAO RZ, et al. Effect of ganoderic acid A on glycolysis and its key rate-limiting enzymes of non-small cell lung cancer PC9 cells[J]. J Jilin Univ(Med Ed), 2024, 50( 3): 682- 688. DOI: 10.13481/j.1671-587X.20240312. 任爱华, 董彦伯, 苗润芝, 等. 灵芝酸A对非小细胞肺癌PC9细胞糖酵解及其关键限速酶的影响[J]. 吉林大学学报(医学版), 2024, 50( 3): 682- 688. DOI: 10.13481/j.1671-587X.20240312.
[31]	LV XC, WU Q, CAO YJ, et al. Ganoderic acid A from Ganoderma lucidum protects against alcoholic liver injury through ameliorating the lipid metabolism and modulating the intestinal microbial composition[J]. Food Funct, 2022, 13( 10): 5820- 5837. DOI: 10.1039/d1fo03219d.
[32]	ZHU J, DING JX, LI SY, et al. Ganoderic acid A ameliorates non-alcoholic streatohepatitis(NASH) induced by high-fat high-cholesterol diet in mice[J]. Exp Ther Med, 2022, 23( 4): 308. DOI: 10.3892/etm.2022.11237.
[33]	MA F, CHANG XJ, WANG GY, et al. Streptococcus suis serotype 2 stimulates neutrophil extracellular traps formation via activation of p38 MAPK and ERK1/2[J]. Front Immunol, 2018, 9: 2854. DOI: 10.3389/fimmu.2018.02854.
[34]	MIELI-VERGANI G, VERGANI D, CZAJA AJ, et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers, 2018, 4: 18017. DOI: 10.1038/nrdp.2018.17.

Relative Articles

[1]	Xingnian ZHOU, Yuhong LIU, Yujie QIN, Quan ZHANG, Mingliang CHENG, Hong LI. Effect of Dendrobium officinale leaf fermentation fluid on a mouse model of alcoholic hepatitis and its mechanism of action[J]. Journal of Clinical Hepatology, 2024, 40(2): 335-342. doi: 10.12449/JCH240218
[2]	Linqi HOU, Zhiyi WANG, Xin ZHAO, Jie ZHANG, Wenting MA, Xuling LIU, Wei ZHANG, Le TAO, Cheng LIU, Liu WU. Therapeutic effect of Xiayuxue decoction on a mouse model of nonalcoholic fatty liver disease induced by high-fat diet and its mechanism[J]. Journal of Clinical Hepatology, 2024, 40(4): 712-719. doi: 10.12449/JCH240412
[3]	Zhurong LI, Chen CHEN, Di GUO, Sixue LYU, Jiawen WU, Na YANG, Yang LIU. Role and mechanism of action of Yinchenhao Decoction in inhibiting ferroptosis of hepatocytes in mice with autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2024, 40(3): 502-508. doi: 10.12449/JCH240311
[4]	Mingming ZHANG, Huan LIU, Dongmei ZHANG, Dongbo WU, Hong TANG. Primary biliary cholangitis-autoimmune hepatitis overlap syndrome comorbid with pulmonary cryptococcosis： A case report[J]. Journal of Clinical Hepatology, 2024, 40(8): 1666-1669. doi: 10.12449/JCH240825
[5]	Zhuoga RENZENG, Kangjie YANG, Yongliang LU, Zhixin WANG, Haijiu WANG. Research advances in neutrophil extracellular traps and liver diseases[J]. Journal of Clinical Hepatology, 2024, 40(3): 639-643. doi: 10.12449/JCH240334
[6]	Kai CHANG, Yanyan WANG, Zhongyong JIANG, Wei SUN, Chenxia LIU, Wanlin NA, Hongxuan XU, Jing XIE, Yuan LIU, Min CHEN. Proteomic analysis and validation of DNA repair regulation in the process of hepatocellular carcinoma recurrence[J]. Journal of Clinical Hepatology, 2024, 40(2): 319-326. doi: 10.12449/JCH240216
[7]	Shixiu PENG, Chunyan LI, Aiping HUANG, Songtao ZHU, Jing MAI, Liping WU. Human immunodeficiency virus infection comorbid with autoimmune hepatitis－primary biliary cholangitis overlap syndrome： A case report[J]. Journal of Clinical Hepatology, 2023, 39(9): 2175-2178. doi: 10.3969/j.issn.1001-5256.2023.09.021
[8]	Yiyan OU, Nana CUI, Yao LI, Qiwei QIAN, Xiong MA, Zhengrui YOU, Min LIAN, Qixia WANG. A preliminary study of the role of neutrophil extracellular traps in patients with primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(4): 810-814. doi: 10.3969/j.issn.1001-5256.2022.04.014
[9]	Luxiang HAN, Huixin TANG, Zhenfeng ZHAO, Shanshan LI, Quanyi WANG, Lingbin KONG, Huiying BI, Zhenfeng SHU, Zhongping DUAN, Yu CHEN, feng HONG. Effect of exosomes from adult human liver-derived stem cells on concanavalin A-induced acute liver injury in mice[J]. Journal of Clinical Hepatology, 2022, 38(5): 1101-1105. doi: 10.3969/j.issn.1001-5256.2022.05.024
[10]	Jianheng HAO, Zhencheng LI, Ying LIU, Yiwen HOU, Yan GAO, Yuchuan MIAO, Yang LIU, Huiqin HAO. A functional analysis of differentially expressed microRNAs involved in liver injury in mice with autoimmune hepatitis induced by concanavalin A[J]. Journal of Clinical Hepatology, 2021, 37(6): 1360-1367. doi: 10.3969/j.issn.1001-5256.2021.06.028
[11]	Yan JIAO, Ying ZHANG, Honglin SHI, Wang LU, Dexi CHEN, Yu CHEN, Hongbo SHI. A bioinformatics analysis of differentially expressed proteins in plasma exosome of acute-on-chronic liver failure patients with different prognoses[J]. Journal of Clinical Hepatology, 2021, 37(4): 834-840. doi: 10.3969/j.issn.1001-5256.2021.04.022
[12]	Gao YuDi, Tian Yuan, Zhang XiangYing, Zhang XiaoHui, Duan ZhongPing, Ren Feng, Chen Yu. Effect of magnesium isoglycyrrhizinate on concanavalin A-induced acute liver failure in mice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1571-1576. doi: 10.3969/j.issn.1001-5256.2020.07.024
[13]	Cao Lin, Li Qian, Ji LongShan, Gao YueQiu, Li Man. Formation mechanism of neutrophil extracellular traps and their role in liver diseases[J]. Journal of Clinical Hepatology, 2020, 36(1): 205-207. doi: 10.3969/j.issn.1001-5256.2020.01.049
[14]	Xiong JingPing, Peng YuanYuan, Zhang YueXin. Screening for differentially expressed proteins in patients with liver cirrhosis complicated by portal vein thrombosis[J]. Journal of Clinical Hepatology, 2018, 34(1): 112-117. doi: 10.3969/j.issn.1001-5256.2018.01.023
[15]	Zhang LiJun, Jia XiaoFang, Wu DaGe, Liu XiaoQian, Huang Yan, Zhang JiaoLi, Cheng NengNeng. Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(10): 1053-1059. doi: 10.3969/j.issn.1001-5256.2014.10.020
[16]	Wang XiaoYu, Luo JianPing, Cha XueQiang, Gu DongXiao. Application of proteomics and metabonomics in studies on alcoholic liver disease[J]. Journal of Clinical Hepatology, 2014, 30(2): 168-173. doi: 10.3969/j.issn.1001-5256.2014.02.018
[17]	Wang JianGang, Fei XinYing, Song Qing. Application of proteomics in study of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 958-960. doi: 10.3969/j.issn.1001-5256.2014.09.030
[18]	Zhang LiJun, Jia XiaoFang, Teng ZhenLin, Cheng NengNeng. Biomarkers of liver cancer related to hepatitis B virus selected by proteomics[J]. Journal of Clinical Hepatology, 2011, 27(5): 553-557.
[20]	Shi Yue, Li YueGuo. Detection and evaluation of serum proteomic patters for hepatocellular carcinoma treated by interventional therapy Using SELDI-TOF-MS protein chip array[J]. Journal of Clinical Hepatology, 2009, 25(2): 122-124.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(5) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (263) PDF downloads(27)

Effect of ganoderic acid A on a mouse model of concanavalin A-induced acute immune liver injury and its mechanism

DOI: 10.12449/JCH241211

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content